Literature DB >> 9373467

Prevalence of age-related maculopathy at two points in time in an elderly British population.

A J Dickinson1, J M Sparrow, A M Duke, J R Thompson, J M Gibson, A R Rosenthal.   

Abstract

UNLABELLED: As the demography of Western society changes, the population prevalence of diseases such as age-related macular degeneration (AMD) is expected to rise. Despite this, there remains a paucity of quality data concerning the population prevalence of AMD, the commonest cause of blindness in the elderly.
PURPOSE: To report the prevalence of AMD at two points in time in an elderly population.
METHOD: A geographically defined random population sample of elderly people was defined in 1980, and studied in 1982-4. In 1990, a cohort of survivors was identified. Participants underwent full ophthalmic examination with fundus photography using the same camera on each occasion. Photographs were randomly encoded and graded by two independent masked observers using the Wisconsin Age-related Maculopathy Grading System. Disagreements were resolved by consensus.
RESULTS: Eighty-eight survivors participated in the follow-up examinations. Of these, 82 subjects had gradable retinal photographs for both examination points in at least one eye. There were 158 pairs of images (initial and subsequent) available for analysis. The mean age was 80 years (range 77-90 years) at the initial examination, and 87 years (range 84-97 years) at the subsequent examination; 70.7% of subjects were female. Prevalence rates for the initial examination were: drusen 72.8%, drusen confluence 37.3%, degeneration of the retinal pigment epithelium (RPE) 51.3%, increased pigment 22.2%, exudative AMD 1.9% and geographic atrophy 1.9%. Rates at second examination were: drusen 62.7% drusen confluence 41.8%, RPE degeneration 72.8%, increased pigment 16.5%, exudative AMD 3.8% and geographic atrophy 3.2%.
CONCLUSION: This 'double' prevalence study provides detailed data on AMD lesions at two points in time in a population-based group of elderly people.

Entities:  

Mesh:

Year:  1997        PMID: 9373467     DOI: 10.1038/eye.1997.66

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years.

Authors:  G Silvestri; M A Williams; C McAuley; K Oakes; E Sillery; D C Henderson; S Ferguson; V Silvestri; K A Muldrew
Journal:  Eye (Lond)       Date:  2012-08-17       Impact factor: 3.775

2.  Screening for hydroxychloroquine retinopathy. Screening should be selective.

Authors:  K May; T Metcalf; A Gough
Journal:  BMJ       Date:  1998-11-14

3.  The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.

Authors:  L-Y Ngai; N Stocks; J M Sparrow; R Patel; A Rumley; G Lowe; G Davey Smith; Y Ben-Shlomo
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

4.  Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand.

Authors:  Piyameth Dilokthornsakul; Nathorn Chaiyakunapruk; Paisan Ruamviboonsuk; Mansing Ratanasukon; Somsanguan Ausayakhun; Akrapope Tungsomeroengwong; Nattapol Pokawattana; Chalakorn Chanatittarat
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

5.  Prevalence of age-related macular degeneration in an elderly UK Caucasian population-The Bridlington Eye Assessment Project: a cross-sectional study.

Authors:  C Wilde; A Poostchi; R L Mehta; H K MacNab; J G Hillman; S A Vernon; W M Amoaku
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

Review 6.  Comparative safety and tolerability of anti-VEGF therapy in age-related macular degeneration.

Authors:  Yasha S Modi; Carley Tanchon; Justis P Ehlers
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

Review 7.  How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

Authors:  C G Owen; A E Fletcher; M Donoghue; A R Rudnicka
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

8.  The burden of age-related macular degeneration: results of a cohort study in two French referral centres.

Authors:  Julia Bonastre; Claude Le Pen; Gisèle Soubrane; Gabriel Quentel
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.